Literature DB >> 10531432

Receptor subtype-induced targeting and subtype-specific internalization of human alpha(2)-adrenoceptors in PC12 cells.

T Olli-Lähdesmäki1, J Kallio, M Scheinin.   

Abstract

The three alpha(2)-adrenergic receptor subtypes have distinct tissue distributions, desensitization properties, and, in some cell types, subtype-specific subcellular localization and trafficking properties. The subtypes also differ in their neuronal physiology. Therefore, we have investigated the localization and targeting of human alpha(2)-adrenoceptors (alpha(2)-AR) in PC12 cells, which were transfected to express the alpha(2)-AR subtypes A, B, and C. Inspection of the receptors by indirect immunofluorescence and confocal microscopy showed that alpha(2A)-AR were mainly targeted to the tips of the neurites, alpha(2B)-AR were evenly distributed in the plasma membrane, and alpha(2C)-AR were mostly located in an intracellular perinuclear compartment. After agonist treatment, alpha(2A)- and alpha(2B)-AR were internalized into partly overlapping populations of intracellular vesicles. Receptor subtype-specific changes in PC12 cell morphology were also discovered: expression of alpha(2A)-AR, but not of alpha(2B)- or alpha(2C)-AR, induced differentiation-like changes in cells not treated with NGF. Also alpha(2B)-AR were targeted to the tips of neurites when they were coexpressed in the same cells with alpha(2A)-AR, indicating that the targeting of receptors to the tips of neurites is a consequence of a change in PC12 cell membrane protein trafficking that the alpha(2A)-subtype induces. The marked agonist-induced internalization of alpha(2A)-AR observed in both nondifferentiated and differentiated PC12 cells contrasts with earlier results from non-neuronal cells and points out the importance of the cellular environment for receptor endocytosis and trafficking. The targeting of alpha(2A)-AR to nerve terminals in PC12 cells is in line with the putative physiological role of this receptor subtype as a presynaptic autoreceptor.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10531432      PMCID: PMC6782893     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  55 in total

1.  Alpha-2A is the predominant alpha-2 adrenergic receptor subtype in human spinal cord.

Authors:  R G Lawhead; H S Blaxall; D B Bylund
Journal:  Anesthesiology       Date:  1992-11       Impact factor: 7.892

2.  Subtype specific recognition of human alpha2C2 adrenergic receptor using monoclonal antibodies against the third intracellular loop.

Authors:  S Liitti; H Närvä; A Marjamäki; J Hellman; J Kallio; M Jalkanen; M T Matikainen
Journal:  Biochem Biophys Res Commun       Date:  1997-04-07       Impact factor: 3.575

3.  Functional alpha 2-adrenergic receptor-Gs coupling undergoes agonist-promoted desensitization in a subtype-selective manner.

Authors:  M G Eason; S B Liggett
Journal:  Biochem Biophys Res Commun       Date:  1993-05-28       Impact factor: 3.575

4.  Molecular characterization of a rat alpha 2B-adrenergic receptor.

Authors:  D W Zeng; J K Harrison; D D D'Angelo; C M Barber; A L Tucker; Z H Lu; K R Lynch
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

5.  Nerve growth factor changes G protein levels and localization in PC12 cells.

Authors:  M Zubiaur; E J Neer
Journal:  J Neurosci Res       Date:  1993-06-01       Impact factor: 4.164

6.  D-amphetamine and L-5-hydroxytryptophan-induced behaviours in mice with genetically-altered expression of the alpha2C-adrenergic receptor subtype.

Authors:  J Sallinen; A Haapalinna; T Viitamaa; B K Kobilka; M Scheinin
Journal:  Neuroscience       Date:  1998-10       Impact factor: 3.590

7.  Specific neural and adrenal medullary antigens detected by antisera to clonal PC12 pheochromocytoma cells.

Authors:  V Lee; M L Shelanski; L A Greene
Journal:  Proc Natl Acad Sci U S A       Date:  1977-11       Impact factor: 11.205

8.  Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor.

Authors:  L A Greene; A S Tischler
Journal:  Proc Natl Acad Sci U S A       Date:  1976-07       Impact factor: 11.205

9.  Subtype-specific differences in the intracellular sorting of G protein-coupled receptors.

Authors:  M von Zastrow; R Link; D Daunt; G Barsh; B Kobilka
Journal:  J Biol Chem       Date:  1993-01-15       Impact factor: 5.157

10.  AN IMPROVED STAINING METHOD FOR ELECTRON MICROSCOPY.

Authors:  J G STEMPAK; R T WARD
Journal:  J Cell Biol       Date:  1964-09       Impact factor: 10.539

View more
  10 in total

1.  Neuron specific alpha-adrenergic receptor expression in human cerebellum: implications for emerging cerebellar roles in neurologic disease.

Authors:  U B Schambra; G B Mackensen; M Stafford-Smith; D E Haines; D A Schwinn
Journal:  Neuroscience       Date:  2005       Impact factor: 3.590

2.  Differential targeting and function of alpha2A and alpha2C adrenergic receptor subtypes in cultured sympathetic neurons.

Authors:  Patricia C Brum; Carl M Hurt; Olga G Shcherbakova; Brian Kobilka; Timothy Angelotti
Journal:  Neuropharmacology       Date:  2006-06-05       Impact factor: 5.250

Review 3.  Intracellular α(2C)-adrenoceptors: storage depot, stunted development or signaling domain?

Authors:  Maqsood A Chotani; Nicholas A Flavahan
Journal:  Biochim Biophys Acta       Date:  2011-05-14

4.  A comparison of agonist-specific coupling of cloned human alpha(2)-adrenoceptor subtypes.

Authors:  J E Rudling; J Richardson; P D Evans
Journal:  Br J Pharmacol       Date:  2000-11       Impact factor: 8.739

Review 5.  Are the pharmacology and physiology of α₂ adrenoceptors determined by α₂-heteroreceptors and autoreceptors respectively?

Authors:  Ralf Gilsbach; Lutz Hein
Journal:  Br J Pharmacol       Date:  2012-01       Impact factor: 8.739

Review 6.  Alpha-2 adrenergic receptors and attention-deficit/hyperactivity disorder.

Authors:  L Cinnamon Bidwell; Rachel E Dew; Scott H Kollins
Journal:  Curr Psychiatry Rep       Date:  2010-10       Impact factor: 5.285

7.  Chronic adrenaline treatment fails to down-regulate the Del301-303-alpha2B-adrenoceptor in neuronal cells.

Authors:  S Salim; A N Desai; M Taneja; D C Eikenburg
Journal:  Br J Pharmacol       Date:  2009-09       Impact factor: 8.739

8.  Dexmedetomidine ameliorates acute lung injury following orthotopic autologous liver transplantation in rats probably by inhibiting Toll-like receptor 4-nuclear factor kappa B signaling.

Authors:  Xinjin Chi; Xiaoxia Wei; Wanling Gao; Jianqiang Guan; Xiaofan Yu; Yiheng Wang; Xi Li; Jun Cai
Journal:  J Transl Med       Date:  2015-06-13       Impact factor: 5.531

9.  Gene expression profiles and signaling mechanisms in α2B-adrenoceptor-evoked proliferation of vascular smooth muscle cells.

Authors:  Anna Huhtinen; Vesa Hongisto; Asta Laiho; Eliisa Löyttyniemi; Dirk Pijnenburg; Mika Scheinin
Journal:  BMC Syst Biol       Date:  2017-06-28

Review 10.  Is There a Role for GPCR Agonist Radiotracers in PET Neuroimaging?

Authors:  Matthieu Colom; Benjamin Vidal; Luc Zimmer
Journal:  Front Mol Neurosci       Date:  2019-10-18       Impact factor: 5.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.